Watchlist Price Alert

Calidi Biotherapeutics In... (CLDI)

AMEX: CLDI · Real-Time Price · USD

0.44

0.03 (6.02%)

At close: May 09, 2025, 10:30 AM

Calidi Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-22.21M	-29.22M	-25.43M	3.39M	-7.94M
Depreciation & Amortization	1.53M	1.26M	260K	153K	117K
Stock-Based Compensation	2.96M	4.81M	6.14M	1.33M	968K
Other Working Capital	-1.07M	-72K	1.95M	-354.71K	652K
Other Non-Cash Items	-279K	2.41M	7.28M	-4.24M	77K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-1.7M	-6.24M	3.57M	-290.87K	945K
Operating Cash Flow	-19.69M	-26.98M	-13.21M	-1.08M	-4.83M
Capital Expenditures	n/a	-585K	-428K	-206K	-351K
Cash Acquisitions	n/a	9K	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	-230M	n/a
Sales Maturities Of Investments	n/a	n/a	190.01M	n/a	n/a
Other Investing Acitivies	-16K	98K	-66K	-9K	-37K
Investing Cash Flow	-16K	-478K	-494K	-230M	-388K
Debt Repayment	1.92M	899K	1.38M	n/a	1.88M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	-1.67M	n/a	n/a	n/a	n/a
Other Financial Acitivies	9.05M	885K	10.71M	-640.13K	-4K
Financial Cash Flow	27.36M	29.04M	12.09M	232.15M	4.7M
Net Cash Flow	7.64M	1.58M	-590.65K	642.65K	-514K
Free Cash Flow	-19.71M	-27.57M	-13.64M	-1.29M	-5.18M